Achmea Investment Management B.V. Raises Position in Teleflex Incorporated (NYSE:TFX)

Achmea Investment Management B.V. increased its holdings in Teleflex Incorporated (NYSE:TFX) by 89.4% during the fourth quarter, according to its most recent disclosure with the SEC. The institutional investor owned 12,250 shares of the medical technology company’s stock after buying an additional 5,782 shares during the period. Achmea Investment Management B.V.’s holdings in Teleflex were worth $2,181,000 as of its most recent SEC filing.

Other institutional investors and hedge funds also recently made changes to their positions in the company. Cooke & Bieler LP raised its position in Teleflex by 22.1% during the fourth quarter. Cooke & Bieler LP now owns 1,078,557 shares of the medical technology company’s stock valued at $191,962,000 after purchasing an additional 195,150 shares in the last quarter. Janus Henderson Group PLC raised its position in Teleflex by 2.8% during the third quarter. Janus Henderson Group PLC now owns 5,376,452 shares of the medical technology company’s stock valued at $1,329,704,000 after purchasing an additional 147,147 shares in the last quarter. FMR LLC raised its position in Teleflex by 70.1% during the third quarter. FMR LLC now owns 269,490 shares of the medical technology company’s stock valued at $66,650,000 after purchasing an additional 111,086 shares in the last quarter. Point72 Asset Management L.P. raised its position in Teleflex by 31.2% during the third quarter. Point72 Asset Management L.P. now owns 407,442 shares of the medical technology company’s stock valued at $100,768,000 after purchasing an additional 96,958 shares in the last quarter. Finally, Parkman Healthcare Partners LLC purchased a new stake in Teleflex during the third quarter valued at about $23,778,000. Hedge funds and other institutional investors own 95.62% of the company’s stock.

Teleflex Stock Up 1.1 %

NYSE TFX opened at $137.79 on Friday. The company has a debt-to-equity ratio of 0.37, a current ratio of 2.42 and a quick ratio of 1.39. The stock has a market capitalization of $6.39 billion, a PE ratio of 27.39, a PEG ratio of 1.73 and a beta of 1.21. Teleflex Incorporated has a 1 year low of $128.55 and a 1 year high of $249.90. The business’s 50-day moving average is $166.99 and its 200 day moving average is $197.99.

Teleflex (NYSE:TFX) last posted its earnings results on Thursday, February 27th. The medical technology company reported $3.89 earnings per share (EPS) for the quarter, topping the consensus estimate of $3.86 by $0.03. The company had revenue of $795.40 million for the quarter, compared to analysts’ expectations of $813.24 million. Teleflex had a return on equity of 14.19% and a net margin of 7.85%. Sell-side analysts forecast that Teleflex Incorporated will post 13.98 earnings per share for the current year.

Teleflex Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Monday, March 17th. Shareholders of record on Friday, March 7th will be given a dividend of $0.34 per share. The ex-dividend date is Friday, March 7th. This represents a $1.36 annualized dividend and a yield of 0.99%. Teleflex’s payout ratio is 95.77%.

Wall Street Analysts Forecast Growth

TFX has been the topic of a number of research reports. Needham & Company LLC restated a “hold” rating on shares of Teleflex in a research report on Wednesday. Piper Sandler reiterated a “neutral” rating and issued a $140.00 price objective (down previously from $255.00) on shares of Teleflex in a report on Friday, February 28th. Bank of America downgraded Teleflex from a “neutral” rating to an “underperform” rating and decreased their price objective for the stock from $235.00 to $140.00 in a report on Tuesday, March 4th. Morgan Stanley decreased their price objective on Teleflex from $275.00 to $191.00 and set an “overweight” rating on the stock in a report on Wednesday, March 5th. Finally, Citizens Jmp downgraded Teleflex from an “outperform” rating to a “market perform” rating in a report on Thursday, February 27th. One research analyst has rated the stock with a sell rating, nine have issued a hold rating and two have given a buy rating to the stock. Based on data from MarketBeat, Teleflex presently has an average rating of “Hold” and an average price target of $182.63.

Teleflex Profile

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.